| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
37 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-84 |
| Cash Flow (TTM) (Millions $) |
14 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Five Prime Therapeutics Inc. is a biotechnology company that specializes in the discovery and development of innovative protein therapeutics for the treatment of various diseases. The company focuses on targeting immune checkpoints and cell surface receptors to develop therapies that can help activate or inhibit cellular pathways involved in disease progression. Five Prime Therapeutics has a diverse pipeline of potential drug candidates, including treatments for solid tumors, hematologic malignancies, and autoimmune diseases. The company utilizes its proprietary protein library and screening technologies to identify and validate new drug targets. Overall, Five Prime Therapeutics aims to bring novel therapies to patients in need, with the goal of improving their outcomes and quality of life.
Company Address: 111 Oyster Point Boulevard South San Francisco 94080 CA
Company Phone Number: 365-5600 Stock Exchange / Ticker: NASDAQ FPRX
|
%